These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 6647870

  • 1. Influence of treatment with prostaglandin synthesis inhibitor or progesterone on cytotoxic activity and progesterone binding capacity of lymphocytes during pregnancy.
    Szekeres-Bartho J, Csernus V, Hadnagy J, Pacsa AS.
    Prostaglandins; 1983 Aug; 26(2):187-95. PubMed ID: 6647870
    [Abstract] [Full Text] [Related]

  • 2. Progesterone-prostaglandin balance influences lymphocyte function in relation to pregnancy.
    Szekeres-Barthó J, Csernus V, Hadnagy J, Pacsa AS.
    Am J Reprod Immunol (1980); 1983 Aug; 4(3):139-41. PubMed ID: 6581738
    [Abstract] [Full Text] [Related]

  • 3. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, Lancet M.
    Am J Obstet Gynecol; 1985 Mar 01; 151(5):574-7. PubMed ID: 3976757
    [Abstract] [Full Text] [Related]

  • 4. Immunologic factors contributing to the initiation of labor--lymphocyte reactivity in term labor and threatened preterm delivery.
    Szekeres-Bartho J, Varga P, Pacsa AS.
    Am J Obstet Gynecol; 1986 Jul 01; 155(1):108-12. PubMed ID: 3460338
    [Abstract] [Full Text] [Related]

  • 5. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S.
    Obstet Gynecol; 2005 Sep 01; 106(3):557-61. PubMed ID: 16135587
    [Abstract] [Full Text] [Related]

  • 6. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW, Lee PA, Zachary AS, Calhoun S, Migeon CJ.
    Obstet Gynecol; 1979 Oct 01; 54(4):412-8. PubMed ID: 492618
    [Abstract] [Full Text] [Related]

  • 7. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL, Kauppila A, Tuimala R.
    Obstet Gynecol; 1980 Dec 01; 56(6):692-5. PubMed ID: 7443111
    [Abstract] [Full Text] [Related]

  • 8. Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo.
    Klebanoff MA, Meis PJ, Dombrowski MP, Zhao Y, Moawad AH, Northen A, Sibai BM, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Leveno KJ, Miodovnik M, Conway D, Wapner RJ, Carpenter M, Mercer BM, Ramin SM, Thorp JM, Peaceman AM, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
    Am J Obstet Gynecol; 2008 Nov 01; 199(5):506.e1-7. PubMed ID: 18456237
    [Abstract] [Full Text] [Related]

  • 9. Cytotoxic activity and progesterone binding capacity of maternal lymphocytes are not influenced by gestational age and by the number of previous pregnancies.
    Szekeres J, Csernus V, Hadnagy J, Pácsa AS.
    Acta Med Acad Sci Hung; 1982 Nov 01; 39(3-4):137-43. PubMed ID: 7185239
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive effect of serum progesterone during pregnancy depends on the progesterone binding capacity of the lymphocytes.
    Szekeres-Bartho J, Csernus V, Hadnagy J, Pacsa AS.
    J Reprod Immunol; 1983 Mar 01; 5(2):81-8. PubMed ID: 6132996
    [Abstract] [Full Text] [Related]

  • 11. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR).
    Am J Obstet Gynecol; 2016 Mar 01; 214(3):376.e1-8. PubMed ID: 26692181
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F, Vaccaro V.
    Minerva Ginecol; 2009 Oct 01; 61(5):401-9. PubMed ID: 19749671
    [Abstract] [Full Text] [Related]

  • 13. The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis.
    Szekeres-Bartho J, Kilaŕ F, Falkay G, Csernus V, Török A, Pacsa AS.
    Am J Reprod Immunol Microbiol; 1985 Sep 01; 9(1):15-8. PubMed ID: 3863495
    [Abstract] [Full Text] [Related]

  • 14. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: a comparison with ritodrine.
    Kauppila A, Hartikainen-Sorri AL, Jänne O, Tuimala R, Järvinen PA.
    Am J Obstet Gynecol; 1980 Oct 15; 138(4):404-8. PubMed ID: 7424996
    [Abstract] [Full Text] [Related]

  • 15. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM, Lewis DF.
    Am J Obstet Gynecol; 2016 Jan 15; 214(1):45-56. PubMed ID: 26558340
    [Abstract] [Full Text] [Related]

  • 16. Clinical use of 17 alpha-hydroxyprogesterone 17-n-caproate in the prevention of premature labor, and its effect upon fetal salvage.
    EICHNER E.
    Ann N Y Acad Sci; 1958 Jul 30; 71(5):787-93. PubMed ID: 13583833
    [No Abstract] [Full Text] [Related]

  • 17. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
    Pirjani R, Heidari R, Rahimi-Foroushani A, Bayesh S, Esmailzadeh A.
    J Obstet Gynaecol Res; 2017 Jan 30; 43(1):57-64. PubMed ID: 27775195
    [Abstract] [Full Text] [Related]

  • 18. ACOG Committee Opinion. Use of progesterone to reduce preterm birth.
    American College of Obstetricians and Gynecologists.
    Obstet Gynecol; 2003 Nov 30; 102(5 Pt 1):1115-6. PubMed ID: 14672496
    [Abstract] [Full Text] [Related]

  • 19. Recurrent hope for the treatment of preterm delivery.
    Doggrell SA.
    Expert Opin Pharmacother; 2003 Dec 30; 4(12):2363-6. PubMed ID: 14640934
    [Abstract] [Full Text] [Related]

  • 20. Endocrine effects of 17 alpha-hydroxyprogesterone caproate during early pregnancy: a double-blind clinical trial.
    Reijnders FJ, Thomas CM, Doesburg WH, Rolland R, Eskes TK.
    Br J Obstet Gynaecol; 1988 May 30; 95(5):462-8. PubMed ID: 3135831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.